Born in Barcelona, Spain and educated in the United States, Dr. Ripoll graduated from the University of Colorado School of Medicine with honors, did her residency and post-doctorate fellowship at Baylor College of Medicine, and received her medical acupuncture training at UCLA.
As an American Urological Association Foundation Scholar, Dr. Ripoll researched genetic predisposition and the role of proto-oncogenes in the development of prostate cancer.
Dr. Ripoll is an expert in prostate cancer with a special interest in brachytherapy, focal, and minimally invasive treatments. She is also a pioneer in the use of MRI fusion prostate biopsy.
Another focus of Dr. Ripoll’s practice is the integrated diagnosis and treatment of chronic painful urological conditions such as chronic prostatitis, chronic testicular pain, interstitial cystitis, female urethral syndrome, and pudendal nerve entrapment.
The HOPE Protocol was created by Dr. Emilia Ripoll to address the chronic conditions that affect many of her urology patients. It combines several types of treatments that build upon each other, activating the body’s innate ability to heal itself.
The HOPE Protocol builds on the work of two medical pioneers: Dr. George Hackett and Dr. Charles Runels. Dr. Hackett recorded over 30,000 lower back and pelvis injections and their effect on his patients. This lifelong study led to the creation of Prolotherapy. Dr. Runels expanded the medical use of PRP to help women who are suffering with stress urinary incontinence, vaginal dryness, and diminished sexual pleasure and men who struggle with erectile dysfunction. Dr. Ripoll combined Dr. Hackett’s injection techniques with Dr. Runels use of PRP, and added her own expertise in hormone optimization to create a new treatment that has rejuvenated the lives of countless patients.
Upcoming Training Dates: